Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 8NETWORK 4NIH 3INDUSTRY 3OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 6Squamous Cell Carcinoma of Head and Neck 3Head and Neck Neoplasms 3Sarcoma, Kaposi 2Neoplasm Metastasis 2Lymphoma, Non-Hodgkin 2Colonic Neoplasms 2Uterine Cervical Dysplasia 1Ulcer 1Tongue Neoplasms 1Stomatitis 1Skin Neoplasms 1Shoulder Injuries 1Shoulder Dislocation 1Salivary Gland Neoplasms 1Salivary Gland Adenoma, Pleomorphic 1Radiodermatitis 1Radiation Injuries 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Parasomnias 1Papillomavirus Infections 1Meningococcal Infections 1Melanoma 1Margins of Excision 1Lymphoma 1Lymphedema 1Lung Neoplasms 1Kidney Transplantation 1Joint Instability 1

Interventions

Valganciclovir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Has results × Acquired Immunodeficiency Syndrome × Clear all
NCT03296553 2022-01-27

Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial.

National Institute of Cancerología

Phase 2 Completed
40 enrolled 6 charts
Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, Immune Reconstitution Inflammatory Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡